Anna-Maria Larsson

Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study

Kristina Lång, Viktoria Josefsson, Anna-Maria Larsson et al. · The Lancet Oncology · 2023 · 509 citations · Full text

Medicine, Health Informatics, Radiology +16

Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients

Caroline Bergenfelz, Anna-Maria Larsson, Kristoffer von Stedingk et al. · PLoS ONE · 2015 · 150 citations · Full text

Medicine, Immunology, Oncology +15

Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study

Veronica Hernström, Viktoria Josefsson, Hanna Sartor et al. · The Lancet Digital Health · 2025 · 115 citations · Full text

Medicine, Computer Science, Preventive Medicine +16

A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation

Henrik Frithiof, Charlotte Welinder, Anna-Maria Larsson et al. · Journal of Translational Medicine · 2015 · 27 citations · Full text

Medicine, Cell Biology, Oncology +15

Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study

Fríða Björk Gunnarsdóttir, Pär‐Ola Bendahl, Alexandra Johansson et al. · Breast Cancer Research · 2023 · 23 citations · Full text

Medicine, Immunology, Oncology +17